Published in TZ Latest News
4 November, 2017 by The TZ Newswire Staff
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clinical Trials on Alzheimer’s Disease Meeting
Presentation Includes New Data from Phase 2a Long-Term Extension Cohort